Bio-Techne
TECH
NZ$83.30
Share price
1.38%
Change (1 day)
-31.66%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Market capitalization of Bio-Techne (TECH)
Market cap: NZ$13.05 Billion
As of June 2025 Bio-Techne has a market cap of NZ$13.05 Billion. This makes Bio-Techne the world's 2129th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Bio-Techne from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$13.05 B | -36.49% |
| 2024 | NZ$20.56 B | 6.56% |
| 2023 | NZ$19.29 B | -5.83% |
| 2022 | NZ$20.49 B | -31.15% |
| 2021 | NZ$29.76 B | 75.16% |
| 2020 | NZ$16.99 B | 36.18% |
| 2019 | NZ$12.47 B | 53.26% |
| 2018 | NZ$8.14 B | 19.14% |
| 2017 | NZ$6.83 B | 23.38% |
| 2016 | NZ$5.53 B | 13.25% |
| 2015 | NZ$4.89 B | 11.75% |
| 2014 | NZ$4.37 B | 2.95% |
| 2013 | NZ$4.25 B | 38.9% |
| 2012 | NZ$3.06 B | -5.42% |
| 2011 | NZ$3.23 B | 2.42% |
| 2010 | NZ$3.15 B | -10.16% |
| 2009 | NZ$3.51 B | -15.62% |
| 2008 | NZ$4.16 B | 23.28% |
| 2007 | NZ$3.38 B | 9.05% |
| 2006 | NZ$3.10 B | -2.82% |
| 2005 | NZ$3.19 B | 41.63% |
| 2004 | NZ$2.25 B | -5.71% |
| 2003 | NZ$2.38 B | 5.38% |
| 2002 | NZ$2.26 B | -38.46% |
| 2001 | NZ$3.68 B | 9.2% |
| 2000 | NZ$3.37 B | 58.48% |
| 1999 | NZ$2.12 B | 164.72% |
| 1998 | NZ$0.80 B | 40.94% |
| 1997 | NZ$0.57 B | 64.07% |
| 1996 | NZ$0.34 B |
End of Day market cap according to different sources
On Jun 17th, 2025 the market cap of Bio-Techne was reported to be:
NZ$12.88 Billion
NZ$12.87 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | NZ$246.44 B | 1,787.31% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | NZ$10.56 B | -19.13% | 🇺🇸 USA |
 Becton Dickinson BDX | NZ$80.35 B | 515.37% | 🇺🇸 USA |
 Danaher DHR | NZ$233.65 B | 1,689.32% | 🇺🇸 USA |
 Qiagen QGEN | NZ$16.76 B | 28.37% | 🇳🇱 Netherlands |
 General Electric GE | NZ$419.71 B | 3,114.21% | 🇺🇸 USA |
 Enzo Biochem ENZB | NZ$44.35 M | -99.66% | 🇺🇸 USA |